Literature DB >> 20163786

Modulation in activation and expression of phosphatase and tensin homolog on chromosome ten, Akt1, and 3-phosphoinositide-dependent kinase 1: further evidence demonstrating altered phosphoinositide 3-kinase signaling in postmortem brain of suicide subjects.

Yogesh Dwivedi1, Hooriyah S Rizavi, Hui Zhang, Rosalinda C Roberts, Robert R Conley, Ghanshyam N Pandey.   

Abstract

BACKGROUND: Phosphoinositide 3-kinase (PI3-K) signaling plays a crucial role in neuronal growth and plasticity. Recently, we demonstrated that suicide brain is associated with decreased activation and expression of selective catalytic and regulatory subunits of PI3-K. The present investigation examined the regulation and functional significance of compromised PI3-K in suicide brain at the level of upstream phosphatase and tensin homologue on chromosome ten (PTEN) and downstream substrates 3-phosphoinositide-dependent kinase 1 (PDK1) and Akt.
METHODS: Messenger RNA expression of Akt1, Akt3, PTEN, and PDK1 by competitive reverse transcription polymerase polymerase chain reaction; protein expression of Akt1, Akt3, PTEN, PDK1, phosphorylated Akt1 (Ser473 and Thr308), phosphorylated PDK1, and phosphorylated PTEN by Western blot; and catalytic activities of Akt1, Akt3, and PDK1 by enzymatic assays were determined in prefrontal cortex and hippocampus obtained from suicide subjects and nonpsychiatric control subjects.
RESULTS: No significant changes in the expression of Akt1 or Akt3 were observed; however, catalytic activity of Akt1, but not of Akt3, was decreased in prefrontal cortex and hippocampus of suicide subjects, which was associated with decreased phosphorylation of Akt1 at Ser473 and Thr308. The catalytic activity of PDK1 and the level of phosphorylated PDK1 were also decreased in both brain areas without any change in expression levels of PDK1. On the other hand, messenger RNA and protein expression of PTEN was increased, whereas the level of phosphorylated PTEN was decreased.
CONCLUSIONS: Our study demonstrates abnormalities in PI3-K signaling at several levels in brain of suicide subjects and suggests the possible involvement of aberrant PI3-K/Akt signaling in the pathogenic mechanisms of suicide. Copyright 2010 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20163786      PMCID: PMC2868089          DOI: 10.1016/j.biopsych.2009.12.031

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  73 in total

1.  Cyclic AMP response element-binding protein in post-mortem brain of teenage suicide victims: specific decrease in the prefrontal cortex but not the hippocampus.

Authors:  Ghanshyam N Pandey; Yogesh Dwivedi; Xinguo Ren; Hooriyah S Rizavi; Rosalinda C Roberts; Robert R Conley
Journal:  Int J Neuropsychopharmacol       Date:  2006-09-18       Impact factor: 5.176

Review 2.  The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism.

Authors:  Jeffrey A Engelman; Ji Luo; Lewis C Cantley
Journal:  Nat Rev Genet       Date:  2006-08       Impact factor: 53.242

3.  Activation of casein kinase II and inhibition of phosphatase and tensin homologue deleted on chromosome 10 phosphatase by nerve growth factor/p75NTR inhibit glycogen synthase kinase-3beta and stimulate axonal growth.

Authors:  María-Angeles Arevalo; Alfredo Rodríguez-Tébar
Journal:  Mol Biol Cell       Date:  2006-05-24       Impact factor: 4.138

Review 4.  Stress, depression, and neuroplasticity: a convergence of mechanisms.

Authors:  Christopher Pittenger; Ronald S Duman
Journal:  Neuropsychopharmacology       Date:  2007-09-12       Impact factor: 7.853

5.  Alteration in kinase activity but not in protein levels of protein kinase B and glycogen synthase kinase-3beta in ventral prefrontal cortex of depressed suicide victims.

Authors:  Félicien Karege; Nader Perroud; Sandra Burkhardt; Michèle Schwald; Eladia Ballmann; Romano La Harpe; Alain Malafosse
Journal:  Biol Psychiatry       Date:  2006-07-28       Impact factor: 13.382

6.  Ras regulates neuronal polarity via the PI3-kinase/Akt/GSK-3beta/CRMP-2 pathway.

Authors:  Takeshi Yoshimura; Nariko Arimura; Yoji Kawano; Saeko Kawabata; Shujie Wang; Kozo Kaibuchi
Journal:  Biochem Biophys Res Commun       Date:  2005-12-06       Impact factor: 3.575

7.  Physiological roles of PKB/Akt isoforms in development and disease.

Authors:  B Dummler; B A Hemmings
Journal:  Biochem Soc Trans       Date:  2007-04       Impact factor: 5.407

8.  Suicide brain is associated with decreased expression of neurotrophins.

Authors:  Yogesh Dwivedi; Amal C Mondal; Hooriyah S Rizavi; Robert R Conley
Journal:  Biol Psychiatry       Date:  2005-08-15       Impact factor: 13.382

9.  Neurotrophin receptor activation and expression in human postmortem brain: effect of suicide.

Authors:  Yogesh Dwivedi; Hooriyah S Rizavi; Hui Zhang; Amal C Mondal; Rosalinda C Roberts; Robert R Conley; Ghanshyam N Pandey
Journal:  Biol Psychiatry       Date:  2008-10-19       Impact factor: 13.382

10.  Akt1 deficiency affects neuronal morphology and predisposes to abnormalities in prefrontal cortex functioning.

Authors:  Wen-Sung Lai; Bin Xu; Koen G C Westphal; Marta Paterlini; Berend Olivier; Paul Pavlidis; Maria Karayiorgou; Joseph A Gogos
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-31       Impact factor: 11.205

View more
  27 in total

1.  The mTOR signaling pathway in the prefrontal cortex is compromised in major depressive disorder.

Authors:  Courtney S Jernigan; Dharmendra B Goswami; Mark C Austin; Abiye H Iyo; Agata Chandran; Craig A Stockmeier; Beata Karolewicz
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2011-05-23       Impact factor: 5.067

2.  Biased allosteric agonism and modulation of metabotropic glutamate receptor 5: Implications for optimizing preclinical neuroscience drug discovery.

Authors:  Kathy Sengmany; Junaid Singh; Gregory D Stewart; P Jeffrey Conn; Arthur Christopoulos; Karen J Gregory
Journal:  Neuropharmacology       Date:  2016-07-05       Impact factor: 5.250

3.  Altered expression of neuroplasticity-related genes in the brain of depressed suicides.

Authors:  B Fuchsova; A Alvarez Juliá; H S Rizavi; A C Frasch; G N Pandey
Journal:  Neuroscience       Date:  2015-04-28       Impact factor: 3.590

Review 4.  Pharmacogenetics of major depressive disorder: top genes and pathways toward clinical applications.

Authors:  Chiara Fabbri; Alessandro Serretti
Journal:  Curr Psychiatry Rep       Date:  2015-07       Impact factor: 5.285

5.  GABAergic control of depression-related brain states.

Authors:  Bernhard Luscher; Thomas Fuchs
Journal:  Adv Pharmacol       Date:  2015-01-14

Review 6.  An overview of the neurobiology of suicidal behaviors as one meta-system.

Authors:  M Sokolowski; J Wasserman; D Wasserman
Journal:  Mol Psychiatry       Date:  2014-09-02       Impact factor: 15.992

Review 7.  Signaling pathways underlying the pathophysiology and treatment of depression: novel mechanisms for rapid-acting agents.

Authors:  Ronald S Duman; Bhavya Voleti
Journal:  Trends Neurosci       Date:  2012-01       Impact factor: 13.837

8.  Expression of p21-activated kinases 1 and 3 is altered in the brain of subjects with depression.

Authors:  Beata Fuchsova; Anabel Alvarez Juliá; Hooriyah S Rizavi; Alberto Carlos Frasch; Ghanshyam N Pandey
Journal:  Neuroscience       Date:  2016-07-27       Impact factor: 3.590

9.  FKBP5 genetic variation: association with selective serotonin reuptake inhibitor treatment outcomes in major depressive disorder.

Authors:  Katarzyna A Ellsworth; Irene Moon; Bruce W Eckloff; Brooke L Fridley; Gregory D Jenkins; Anthony Batzler; Joanna M Biernacka; Ryan Abo; Abra Brisbin; Yuan Ji; Scott Hebbring; Eric D Wieben; David A Mrazek; Richard M Weinshilboum; Liewei Wang
Journal:  Pharmacogenet Genomics       Date:  2013-03       Impact factor: 2.089

10.  Reduced phosphorylation of the mTOR signaling pathway components in the amygdala of rats exposed to chronic stress.

Authors:  Agata Chandran; Abiye H Iyo; Courtney S Jernigan; Beata Legutko; Mark C Austin; Beata Karolewicz
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2012-08-07       Impact factor: 5.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.